Decreased Chronic GvHD With Post‐Transplant Cyclophosphamide Versus ATG in Patients With Myelofibrosis Allografted With an Unrelated Donor: A Study From the Chronic Malignancies Working Party of the EBMT

Documenti analoghi

• Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT
  di: Juan Carlos Hernández‐Boluda, et al.
  Pubblicazione: (2025)
• Methotrexate Versus Mycophenolate Mofetil Prophylaxis in Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Malignancies: A Retrospective Analysis on Behalf of the Chronic Malignancies Working Party of the EBMT
  di: Thomas Luft, et al.
  Pubblicazione: (2024)
• Increased Plasma ST2 Levels Precede the Development of Severe Acute GvHD and Chronic GvHD After Pediatric Hematopoietic Stem Cell Transplantation
  di: Nakisa Kamari‐Kany, et al.
  Pubblicazione: (2025)
• Comment on: Increased Plasma ST2 Levels Precede the Development of Severe Acute GvHD and Chronic GvHD After Pediatric Hematopoietic Stem Cell Transplantation
  di: Yusa Pan, et al.
  Pubblicazione: (2025)
• Green Plasma in Extracorporeal Photopheresis: A Case Report in Overlap Chronic GvHD
  di: Yandy Marx Castillo‐Aleman, et al.
  Pubblicazione: (2025)